Ashwin A. Patkar, MD
- 15Articles
- 68.6KReads
- 1996–2021Active
- 48Collaborators
- 1.2KCitations
About
Ashwin A. Patkar, MD, has authored 15 articles published between 1996 and 2021, focusing on mood disorders including major depressive disorder and bipolar depression, as well as schizophrenia, schizoaffective disorders, anxiety, somatoform disorders, and cognition. The research covers clinical trials of pharmacologic treatments such as citalopram, vilazodone, milnacipran, lisdexamfetamine, selegiline, armodafinil, and quetiapine, investigating their efficacy, safety, and tolerability. Patkar's work also addresses topics related to opioid overdose prevention and augmentation strategies for depressive disorders. Frequent collaborators include Prakash S. Masand, Chi-Un Pae, and David M. Marks.
Publications
Efficacy of Citalopram Treatment in Bipolar Depression
January 12, 2021
An 8-Week Randomized, Double-Blind Trial Comparing Efficacy, Safety, and Tolerability of 3 Vilazodone Dose-Initiation Strategies Following Switch From SSRIs and SNRIs in Major Depressive Disorder
August 6, 2015
A Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of Milnacipran for Chronic Radicular Pain (Sciatica) Associated With Lumbosacral Disc Disease
August 15, 2014
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
